Pharma and Biotech
| Notice of AGM | 21-May-2026 | 07:51 | RNS |
| Issue of Options, Salary Waivers, Incentive Plan | 07-May-2026 | 07:00 | RNS |
| Conversion of Convertible Loan Notes | 06-May-2026 | 07:00 | RNS |
| Final results for the year ended 31 December 2025 | 30-Apr-2026 | 07:00 | RNS |
| £250,000 Funding Facility | 02-Apr-2026 | 07:00 | RNS |
| Progress on Launch of Biomarker Test in USA | 23-Feb-2026 | 07:00 | RNS |
| Patent Granted in Canada | 04-Feb-2026 | 07:00 | RNS |
| £250,000 Convertible Loan Note Issue | 05-Nov-2025 | 07:01 | RNS |
| LOI with leading UK Clinical Diagnostic Group | 05-Nov-2025 | 07:00 | RNS |
| Change of Registered Office | 27-Oct-2025 | 11:32 | RNS |
| Interim Results | 30-Sep-2025 | 07:00 | RNS |
| Update on Clinical Laboratory Partnerships in USA | 29-Sep-2025 | 07:00 | RNS |
| Commercial Progress in USA | 18-Aug-2025 | 07:00 | RNS |
| Result of AGM | 30-Jun-2025 | 13:45 | RNS |
| Notice of AGM | 06-Jun-2025 | 11:00 | RNS |
| Currency | UK Pounds |
| Share Price | 2.90p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 3.73 |
| 52 Week Low | 1.29 |
| Volume | 591,018 |
| Shares Issued | 396.39m |
| Market Cap | £11.50m |
| Beta | 0.02 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:26 | 100,000 @ 2.87p |
| 15:41 | 30,000 @ 3.07p |
| 14:19 | 96 @ 3.10p |
| 11:24 | 48,781 @ 2.87p |
| 11:22 | 58 @ 2.70p |
| Finance Director | Nigel Ronald Lee |
You are here: research